| 000 | 00878 a2200241 4500 | ||
|---|---|---|---|
| 005 | 20250513002159.0 | ||
| 264 | 0 | _c19830407 | |
| 008 | 198304s 0 0 eng d | ||
| 022 | _a0004-8291 | ||
| 024 | 7 |
_a10.1111/j.1445-5994.1982.tb02641.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aO'Rourke, M F | |
| 245 | 0 | 0 |
_aMyocardium infarcting? _h[electronic resource] |
| 260 |
_bAustralian and New Zealand journal of medicine _cDec 1982 |
||
| 300 |
_a581-2 p. _bdigital |
||
| 500 | _aPublication Type: Editorial | ||
| 650 | 0 | 4 |
_aFibrinolytic Agents _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMyocardial Infarction _xdrug therapy |
| 650 | 0 | 4 | _aTerminology as Topic |
| 773 | 0 |
_tAustralian and New Zealand journal of medicine _gvol. 12 _gno. 6 _gp. 581-2 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1445-5994.1982.tb02641.x _zAvailable from publisher's website |
| 999 |
_c6962384 _d6962384 |
||